COMPARISON OF PREDISPOSING FACTORS FOR THE DEVELOPMENT OF DRUG SUSCEPTIBLE AND DRUG RESISTANT PULMONARY TB RE-TREATMENT CASES

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 33

Abstract

BACKGROUND At present, multidrug resistant (MDR-TB) is a challenge in global efforts to prevent and control tuberculosis. WHO reports estimate that 3.5% of newly diagnosed TB patients and 20.5% of previously treated patients had MDR-TB.1,2 Known risk factors for emergence of MDR TB include age, sex, number of times exposed to ATT treatment, HIV status and alcoholism. 3,4,5 The aim of the study is to compare the predisposing factors towards the development of drug susceptible and drug resistant PTB among retreatment cases. MATERIALS AND METHODS This study was conducted among 300 retreatment pulmonary tuberculosis patients attending Government Hospital of Thoracic Medicine, Tambaram sanatorium from 2016-18. 150 patients each of drug (Rifampicin) sensitive and drug resistant (Rifampicin) TB diagnosed by CBNAAT were selected by simple random sampling. Detailed data including demographic particulars, treatment history, personal history, HIV status were collected using a standardised questionnaire and the results were statistically analysed. RESULTS Age >45 years, male sex, lower educational status, history of treatment interruption, HIV positive status, smoking and alcoholism were found to have a statistically significant correlation with the development of drug resistant TB. CONCLUSION Several factors contribute to the development of drug resistant tuberculosis. If the goal of eliminating TB by 2025 is to be achieved, the focus should be on the prevention of development of drug resistant TB by ensuring that patients take full course of treatment properly the first time. Knowledge of factors associated with drug resistant TB will help us to plan better intervention strategies such as pretreatment counselling, smoking and alcohol cessation clinic.

Authors and Affiliations

Balaji Ganapathi Kothandapani, Sridhar Rathinam, Vinod Kumar Viswanathan, Kumar Satagopan

Keywords

Related Articles

ROLE OF PALLIATIVE RADIOTHERAPY AND BEST SUPPORTIVE CARE IN LOCALLY ADVANCED CARCINOMA LUNG

BACKGROUND Lung cancer is presently the leading cause of cancer death and most of the patients present in advanced stage where symptom palliation is the main aim. However, there is no well-defined recommendation regardin...

CORRELATION OF PROGNOSIS AND RENAL DYSFUNCTION WITH CLINICAL AND LAB PROFILE IN PLASMA CELL NEOPLASMS

BACKGROUND Plasma cell neoplasms are characterised by clonal proliferation and accumulation of immunoglobulin producing B cells that typically secrete a monoclonal immunoglobulin called M-protein.1 Multiple myeloma is th...

TUBERCULOUS INFECTION IN NECK- STILL A HEALTH PROBLEM

The proportion of extra-pulmonary presentation of tuberculosis is on the rise in comparison to pulmonary tuberculosis. Neck is the commonest extra-pulmonary site of tuberculosis in our country. Absence of typical feature...

STUDY OF METABOLIC ACIDOSIS IN PATIENTS UNDERGOING SURGERIES OF OPERATIVE TIME GREATER THAN 2 HOURS DURATION

BACKGROUND Metabolic acidosis is proven complication of major surgery, but very less significance is given to it. Metabolic acidosis has a significant effect in postoperative recovery and morbidity of patients undergoing...

CLINICO-HISTOPATHOLOGICAL STUDY OF THYROID LESIONS IN A TERTIARY CARE CENTER OVER A PERIOD OF ONE YEAR

BACKGROUND Thyroid nodules are common in clinical practice, occurring globally with wide variation in incidence and histopathological pattern related to age, sex, dietary and environmental factors. This study was underta...

Download PDF file
  • EP ID EP571009
  • DOI 10.18410/jebmh/2018/502
  • Views 89
  • Downloads 0

How To Cite

Balaji Ganapathi Kothandapani, Sridhar Rathinam, Vinod Kumar Viswanathan, Kumar Satagopan (2018). COMPARISON OF PREDISPOSING FACTORS FOR THE DEVELOPMENT OF DRUG SUSCEPTIBLE AND DRUG RESISTANT PULMONARY TB RE-TREATMENT CASES. Journal of Evidence Based Medicine and Healthcare, 5(33), 2436-2438. https://europub.co.uk/articles/-A-571009